Filed: 5/11/2023ACC: 0000950123-23-004367
📋 What this filing means
VERSANT VENTURE MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 7 equity positions with a total reported market value of $47.97M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
7
Positions
$47.97M
Total AUM (reported)
18.63M
Total Shares
Allocation by class
COMMON STOCK$25.42M53.0%
COMMON SHARES$22.55M47.0%
Portfolio Concentration
Top 3$37.20M77.5%
4–10$10.77M22.5%
Top 3 weight
77.5%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 18.63M
Sole
Full voting authority
0.00
shares
% of voting shares0.0%
Shared
Joint voting authority
18.63M
shares
% of voting shares100.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other7
Dominant voting typeShared · 100.0% of voting shares
Institutional Holdings7
Rows:
CRISPR Therapeutics AG
OTRShares498.56K
TypeSH
Market value$22.55M
47.01%
Sole
0.00
Shared
498.56K
None
0.00
Gritstone Oncology, Inc.
OTRShares3.56M
TypeSH
Market value$9.90M
20.64%
Sole
0.00
Shared
3.56M
None
0.00
Passage Bio, Inc.
OTRShares4.96M
TypeSH
Market value$4.75M
9.90%
Sole
0.00
Shared
4.96M
None
0.00
CymaBay Therapeutics, Inc.
OTRShares543.75K
TypeSH
Market value$4.74M
9.88%
Sole
0.00
Shared
543.75K
None
0.00
Adverum Biotechnologies, Inc.
OTRShares5.07M
TypeSH
Market value$3.64M
7.58%
Sole
0.00
Shared
5.07M
None
0.00
Aligos Therapeutics, Inc.
OTRShares2.32M
TypeSH
Market value$2.03M
4.23%
Sole
0.00
Shared
2.32M
None
0.00
Minerva Surgical Inc.
OTRShares1.67M
TypeSH
Market value$367.4K
0.77%
Sole
0.00
Shared
1.67M
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
CRISPR Therapeutics AGOTR | Common Shares | 498.56K | SH | $22.55M 47.01% | 0.00 | 498.56K | 0.00 |
Gritstone Oncology, Inc.OTR | Common Stock | 3.56M | SH | $9.90M 20.64% | 0.00 | 3.56M | 0.00 |
Passage Bio, Inc.OTR | Common Stock | 4.96M | SH | $4.75M 9.90% | 0.00 | 4.96M | 0.00 |
CymaBay Therapeutics, Inc.OTR | Common Stock | 543.75K | SH | $4.74M 9.88% | 0.00 | 543.75K | 0.00 |
Adverum Biotechnologies, Inc.OTR | Common Stock | 5.07M | SH | $3.64M 7.58% | 0.00 | 5.07M | 0.00 |
Aligos Therapeutics, Inc.OTR | Common Stock | 2.32M | SH | $2.03M 4.23% | 0.00 | 2.32M | 0.00 |
Minerva Surgical Inc.OTR | Common Stock | 1.67M | SH | $367.4K 0.77% | 0.00 | 1.67M | 0.00 |